To date, the CCNK protein has been studied as a potential biomarker among tumors associated with non-small-cell lung cancer [15,24], the prostate gland [25], the testis [26], and the hematopoietic system [27]. The gene discussed is CCNK; the disease is non-small cell lung carcinoma.